Tag: Gastrointestinal Problems
FDA Approves First Pill for Fecal Transplant Therapy
Vowst is approved to prevent recurrence of C. difficile; pill contains live gut bacteria from stool samples donated by healthy people
High-Dose VE303 Prevents Recurrent Clostridioides Difficile Infection
CDI recurrence rates were significantly lower with high-dose VE303 bacterial consortium versus placebo
Rates of Irritable Bowel Syndrome Increased After COVID-19 Hospitalization
Rate of patients fulfilling criteria for depression was also higher for COVID-19 patients versus controls
Updated Guidance Provided for GI Clinicians on Alpha-Gal Syndrome
Subset of alpha-gal allergic patients show gastrointestinal symptoms without skin changes or anaphylaxis
Risk for GI Disorders Increased After Acute Phase of COVID-19
Risks were seen in patients who were not hospitalized, and increased across the severity spectrum of acute COVID-19
Over-the-Scope Clip Beneficial for Nonvariceal Upper GI Bleeding
Over-the-scope clip was better than standard treatment at reducing 30-day risk for further bleeding
Food Elimination Diets Compared in Eosinophilic Esophagitis
Histological remission rates similar with one-, six-food elimination diets for adults with eosinophilic esophagitis
CDC Warns of Rise of Drug-Resistant Shigella Bacteria
Shigella is easily spread, and limited treatment options exist for patients infected with XDR strains
Long-Term Outcomes Explored After Chronic Pancreatitis Surgery
Ten-year overall survival is 63.5 percent; only persistent opioid use associated with worse overall survival in multivariable modeling
Nab-Paclitaxel Does Not Increase Overall Survival in Biliary Tract Cancer
No significant improvement seen in survival with gemcitabine and cisplatin for patients with locally advanced disease, gallbladder adenocarcinoma
